Presence and Determinants of Cardiovascular Disease and Mortality in Individuals With Type 1 Diabetes of Long Duration: The FinnDiane 50 Years of Diabetes StudyValma Harjutsalo, Per‐Henrik Groop, Draženka Pongrac Barlovič et al.|Diabetes Care|2021Cited by 63
Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trialHiddo J.L. Heerspink, Janet B. McGill, Jay S. Skyler et al.|Diabetes Research and Clinical Practice|2023Cited by 57
The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-upDraženka Pongrac Barlovič, Per‐Henrik Groop, Valma Harjutsalo et al.|Diabetes Care|2018Cited by 40
Genetic and epigenetic background of diabetic kidney diseaseNiina Sandholm, Per‐Henrik Groop|Frontiers in Endocrinology|2023Cited by 35
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetesVikas S. Sridhar, David Z.I. Cherney, Christine P. Limonte et al.|Diabetologia|2023Cited by 25